sulfadoxine has been researched along with Hematologic Malignancies in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Averbuch, D; Masarwa, R; Shayovitz, V; Stepensky, P; Temper, V; Vinker-Shuster, M | 1 |
| Abe, D; Iseki, T; Kawaguchi, T; Muto, T; Nakaseko, C; Ohwada, C; Sakai, S; Sakaida, E; Shimizu, N; Takeda, Y; Takeuchi, M; Tanaka, S; Tsukamoto, S; Yokote, K | 1 |
1 trial(s) available for sulfadoxine and Hematologic Malignancies
| Article | Year |
|---|---|
Gram-negative Bacteremia in Children With Hematologic Malignancies and Following Hematopoietic Stem Cell Transplantation: Epidemiology, Resistance, and Outcome.
Topics: Adolescent; Allografts; Bacteremia; Child; Child, Preschool; Drug Combinations; Drug Resistance, Bacterial; Female; Gentamicins; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Infant; Infant, Newborn; Male; Neutropenia; Piperacillin; Pneumocystis carinii; Pneumocystis Infections; Retrospective Studies; Sulfadoxine; Trimethoprim | 2019 |
1 other study(ies) available for sulfadoxine and Hematologic Malignancies
| Article | Year |
|---|---|
Low-dose trimethoprim-sulfamethoxazole for Pneumocystis jiroveci pneumonia prophylaxis after allogeneic hematopoietic SCT.
Topics: Adolescent; Adult; Anti-Infective Agents; Drug Combinations; Female; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Male; Middle Aged; Pneumocystis carinii; Pneumonia, Pneumocystis; Sulfadoxine; Transplantation, Homologous; Trimethoprim | 2011 |